Clifford Swan Investment Counsel LLC lessened its position in shares of Clorox Co (NYSE:CLX) by 3.3% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 17,323 shares of the company’s stock after selling 600 shares during the quarter. Clifford Swan Investment Counsel LLC’s holdings in Clorox were worth $2,577,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Dupont Capital Management Corp acquired a new stake in shares of Clorox during the 3rd quarter worth approximately $199,000. Smith Moore & CO. acquired a new stake in shares of Clorox during the 3rd quarter worth approximately $204,000. Private Asset Management Inc. acquired a new stake in shares of Clorox during the 4th quarter worth approximately $208,000. Lourd Capital LLC acquired a new stake in shares of Clorox during the 4th quarter worth approximately $210,000. Finally, Gratus Capital LLC acquired a new stake in shares of Clorox during the 3rd quarter worth approximately $215,000. 74.11% of the stock is owned by institutional investors and hedge funds.
Shares of Clorox Co (NYSE CLX) opened at $131.70 on Monday. Clorox Co has a 52-week low of $124.09 and a 52-week high of $150.40. The company has a debt-to-equity ratio of 2.35, a current ratio of 1.22 and a quick ratio of 0.86. The stock has a market cap of $17,042.51, a price-to-earnings ratio of 21.73, a P/E/G ratio of 2.47 and a beta of 0.31.
Clorox (NYSE:CLX) last posted its quarterly earnings results on Friday, February 2nd. The company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.01. Clorox had a net margin of 13.21% and a return on equity of 126.70%. The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter last year, the firm posted $1.14 EPS. Clorox’s revenue was up .7% compared to the same quarter last year. equities analysts forecast that Clorox Co will post 6.23 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 11th. Shareholders of record on Wednesday, April 25th will be paid a dividend of $0.96 per share. The ex-dividend date is Tuesday, April 24th. This is a boost from Clorox’s previous quarterly dividend of $0.84. This represents a $3.84 annualized dividend and a yield of 2.92%. Clorox’s dividend payout ratio (DPR) is 55.45%.
In other Clorox news, SVP Michael R. Costello sold 10,574 shares of the firm’s stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the transaction, the senior vice president now directly owns 34,867 shares in the company, valued at approximately $4,742,260.67. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.00% of the stock is currently owned by company insiders.
Several analysts have recently commented on CLX shares. Jefferies Group reaffirmed a “hold” rating and set a $132.00 price objective on shares of Clorox in a research report on Wednesday, November 1st. Morgan Stanley reduced their price objective on shares of Clorox from $138.00 to $128.00 and set an “equal weight” rating for the company in a research report on Thursday, November 2nd. Zacks Investment Research raised shares of Clorox from a “sell” rating to a “hold” rating in a research report on Monday, November 6th. Consumer Edge raised shares of Clorox from a “neutral” rating to an “outperform” rating in a research report on Friday, November 10th. Finally, Deutsche Bank initiated coverage on shares of Clorox in a research report on Wednesday, December 13th. They set a “hold” rating and a $142.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and four have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $132.46.
ILLEGAL ACTIVITY NOTICE: “Clorox Co (CLX) Holdings Trimmed by Clifford Swan Investment Counsel LLC” was published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.thelincolnianonline.com/2018/02/19/clorox-co-clx-holdings-trimmed-by-clifford-swan-investment-counsel-llc.html.
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.